In-Vitro Efficacy of Synergistic Antibiotic Combinations in Multidrug Resistant Pseudomonas Aeruginosa Strains

키워드

참고문헌 (34)

1. Pier GB, "Pseudomonas aeruginosa. In Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. Volume 2. 6 th edition.", pp.2587~2615 (2005), Churchill Livingstone
2. Clinical and laboratory standards institute, "Performance standards for antimicrobial disk susceptibility tests", CLSI Document M2-A9 9th edition. Wayne, PA, USA: CLSI, ~ (2006)
3. Clinical and laboratory standards institute, "Performance standards for antimicrobial susceptibility testing", CLSI Document M100-S16 16th edition. Wayne, PA, USA: CLSI, ~ (2006)
4. Barry AL, "Interpretive standards for disk susceptibility tests with Sch21420 and amikacin", Antimicrob Agent Chemother, 18, pp.616~621 (1980)
5. Clinical and laboratory standards institute, "Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically", CLSI Document M7A6 6th edition. Wayne, PA, USA: CLSI, ~ (2003)
6. Moody JA, "Tests to assess bactericidal acivity. In Clincal microbiology procedures handbook. Volume 2. 2nd edition.", pp.5~17 (2004), ASM Press
7. Moody J, "Synergism testing: Broth microdilution checkerboard and broth macrodilution methods. In Clincal microbiology procedures handbook. Volume 2. 2nd edition", pp.5~23 (2004), ASM Press
8. Eliopoulos GM, "Antimicrobial Combinations. In Antibiotics in Laboratory Medicine. 4 th edition.", pp.330~396 (1996), Williams & Wilkins
9. Sader HS, "Contemporary in vitro synergy rates for aztreonam combined with newer fluoroquinolones and beta-lactams tested against gram-negative bacilli", Diagn Microbiol Infect Dis, 47, pp.547~550 (2003)
10. Giamarellou H, "Aminoglycosides plus beta-lactams against gram-negative organisms. in Evaluation of in vitro synergy and chemical interactions", Am J Med, 80, pp.126~137 (1986)
11. Weiss K, "Routine susceptibility testing of four antibiotic combinations for improvement of laboratory guide to therapy of cystic fibrosis infections caused by Pseudomonas aeruginosa", Antimicrob Agent Chemother, 39, pp.2411~2414 (1995)
12. Owens RC JR, "In vitro synergistic activities of tobramycine and selected beta-lactams against 75 gram-negative clinical isolates", Antimicrob Agent Chemother, 41, pp.2586~2588 (1997)
13. Chan EL, "Determination of synergy by two methods with eight antimicrobial combinations against tobramycinsusceptible and tobramycin-resistant strains of Pseudomonas", Diagn Microbiol Infect Dis, 6, pp.157~164 (1987)
14. Baltch AL, "Synergy with cefsulodin or piperacillin and three aminoglycosides or aztreonam against aminoglycoside resistant strains of Pseudomonas aeruginosa", J Antimicrob Chemother, 27, pp.801~808 (1991)
15. Perea EJ, "Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa", J Antimicrob Chemother, 6, pp.471~477 (1980)
16. Oie S, "In vitro effects of a combination of antipseudomonal antibiotics against multi-drug resistant Pseudomonas aeruginosa", J Antimicrob Chemother, 44, pp.689~691 (1999)
17. Giamarellos-Bourboulis EJ, "Comparative in vitro interactions of ceftazidime, meropenem and imipenem with amikacin on multiresistant Pseudomonas aeruginosa", Diagn Microbiol Infect Dis, 29, pp.81~86 (1997)
18. Clark RB, "Synergistic activity of aminoglycoside-beta-lactam combinations against Pseudomonas aeruginosa with an unusual aminoglycoside antibiogram", Med Microbiol Immunol, 179, pp.77~86 (1990)
19. Gerçeker AA, "In vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa", J Antimicrob Chemother, 36, pp.707~711 (1995)
20. Bustamante CI, "Synergism of the combinations of imipenem plus ciprofloxacin and imipenem plus amikacin against Pseudomonas aeruginosa and other bacterial pathogens", Antimicrob Agent Chemother, 31, pp.632~634 (1987)
21. Gould IM, "In vitro pharmacodynamic studies of piperacillin", tazobactam with gentamicin and ciprofloxacin, 1997, pp.39, 53~61
22. Laverdière M, "In vitro synergism of ceftriaxone combined with aminoglicosides against Pseudomonas aeruginosa", Diagn Microbiol Infect Dis, 19, pp.39~46 (1994)
23. den Hollander JG, "Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model", Antimicrob Agents Chemother, 41, pp.95~100 (1997)
24. Jones RN, "Antimicrobial activity of isepamicin (SCH21420, 1-N-HAPA gentamicin B) combinations with cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, imipenem, mezlocillin and piperacillin tested against gentamicin-resistant and susceptible gram-negative bacilli and enterococci", J Chemother, 3, pp.289~294 (1991)
25. Song W, "In vitro activity of betalactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginsa", Int J Antimicrob Agents, 1, pp.8~12 (2003)
26. Burgess DS, "Activity of piperacillin", tazobactam in combination with amikacin, ciprofloxacin and travofloxacin against Pseudomonas aeruginosa by time-kill, 2000, pp.38, 37~41
27. Isenberg HD, "In vitro activity of ciprofloxacin, levofloxacin and travafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia", Diagn Microbiol Infect Dis, 33, pp.81~86 (1999)
28. Neu HC, "Synergy and antagonism of combinations with quinolones", Eur J Clin Microbiol Infect Dis, 10, pp.255~261 (1991)
29. Fish DN, "Synergic activity of cephalosporins plus fluoroquinolones against Pseudomonas aeruginosa with resistance to one or both drugs", J Antimicrob Chemother, 50, pp.1045~1049 (2002)
30. Drago L, "Activity of levofloxacin and ciprofloxacin with cefepime, ceftazidime, imipenem, piperacillin-tazobactam and amikacin against different Pseudomonas aeruginosa phenotypes and Acinetobacter spp", Chemotherapy, 50, pp.202~210 (2004)
31. Mayer I, "Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp", J Antimicrob Chemother, 43, pp.651~657 (1999)
32. Andes DR, "Cephalosporins. In Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. Volume 1. 6 th edition.", pp.294~311 (2005), Churchill Livingstone
33. Gilbert DN, "Aminoglycosides. In Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. Volume 1. 6 th edition.", pp.328~356 (2005), Churchill Livingstone
34. Perry CM, "Piperasillin", tazobactam an updated review of its use in the treatment of bacterial infections, 1999, pp.57, 805~843

관련 논문AI추천